Lanean...

Target Therapy in Hematological Malignances: New Monoclonal Antibodies

Apart from radio- and chemotherapy, monoclonal antibodies (MoAbs) represent a new, more selective tool in the treatment of hematological malignancies. MoAbs bind with the specific antigens of the tumors. This interaction is a basis for targeted therapies which exhibit few side effects and significan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int Sch Res Notices
Egile Nagusiak: Podhorecka, Monika, Markowicz, Justyna, Szymczyk, Agnieszka, Pawlowski, Johannes
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4897146/
https://ncbi.nlm.nih.gov/pubmed/27433507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/701493
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!